BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Imhann F, Van der Velde KJ, Barbieri R, Alberts R, Voskuil MD, Vila AV, Collij V, Spekhorst LM, Van der Sloot KWJ, Peters V, Van Dullemen HM, Visschedijk MC, Festen EAM, Swertz MA, Dijkstra G, Weersma RK. Correction to: The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1. BMC Gastroenterol 2019;19:44. [PMID: 30917794 DOI: 10.1186/s12876-019-0938-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Peng J, Jury EC, Dönnes P, Ciurtin C. Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges. Front Pharmacol 2021;12:720694. [PMID: 34658859 DOI: 10.3389/fphar.2021.720694] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
2 Ryvchin R, Dubinsky V, Rabinowitz K, Wasserberg N, Dotan I, Gophna U. Alteration in urease-producing bacteria in the gut microbiomes of patients with inflammatory bowel diseases. J Crohns Colitis 2021:jjab101. [PMID: 34111242 DOI: 10.1093/ecco-jcc/jjab101] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Wu J, Li C, Bai L, Wu J, Bo R, Ye M, Huang L, Chen H, Rui W. Structural differences of polysaccharides from Astragalus before and after honey processing and their effects on colitis mice. Int J Biol Macromol 2021;182:815-24. [PMID: 33857512 DOI: 10.1016/j.ijbiomac.2021.04.055] [Reference Citation Analysis]
4 Ruigrok RAAA, Collij V, Sureda P, Klaassen MAY, Bolte LA, Jansen BH, Voskuil MD, Fu J, Wijmenga C, Zhernakova A, Weersma RK, Vich Vila A. The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease. J Crohns Colitis 2021;15:1326-38. [PMID: 33515008 DOI: 10.1093/ecco-jcc/jjab020] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
5 van der Sloot KWJ, Voskuil MD, Blokzijl T, Dinkla A, Ravesloot L, Visschedijk MC, van Dullemen HM, Festen EAM, Alizadeh BZ, van Leer-Buter C, Weersma RK, van Goor H, Koets AP, Dijkstra G. Isotype-specific Antibody Responses to Mycobacterium avium paratuberculosis Antigens Are Associated With the Use of Biologic Therapy in Inflammatory Bowel Disease. J Crohns Colitis 2021;15:1253-63. [PMID: 33378524 DOI: 10.1093/ecco-jcc/jjaa263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 van der Sloot KWJ, Weersma RK, Alizadeh BZ, Dijkstra G. Identification of environmental risk factors associated with the development of Inflammatory Bowel Disease. J Crohns Colitis 2020:jjaa114. [PMID: 32572465 DOI: 10.1093/ecco-jcc/jjaa114] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]